Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04296071 · ClinicalTrials.gov registry record
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
A clinical trial of Cardiopulmonary Bypass and Lung Injury, sponsored by Sophia Koutsogiannaki.
- Recruiting
- Registry status
- 56
- Enrollment target
- 1
- Study location
NCT04296071 is a study of Cardiopulmonary Bypass and Lung Injury that is actively recruiting participants, run by Sophia Koutsogiannaki. The registered enrollment target is 56 participants, below the 738-participant average among 9 other Cardiopulmonary Bypass trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04296071, a study of Cardiopulmonary Bypass and Lung Injury, is actively recruiting participants, sponsored by Sophia Koutsogiannaki.
- RECRUITING
- Registry status
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.
Conditions Studied
Interventions
- OTHER Research study
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-10-14 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04296071
The ClinicalTrials.gov registry entry for NCT04296071 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 738-participant average among 9 other Cardiopulmonary Bypass trials with a reported enrollment target (92% lower). The listed sponsor is Sophia Koutsogiannaki, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiopulmonary Bypass appearing as the primary indexed condition, and to 1 intervention - of which Research study is the first listed.
NCT04296071 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04296071 about?
NCT04296071 is a clinical study titled "Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)". Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.
What is the current status of trial NCT04296071?
This trial is currently recruiting. The enrollment target is 56 participants. The study started on 2022-10-14. Estimated completion is 2026-12.
What conditions does trial NCT04296071 study?
This clinical trial studies the following conditions: Cardiopulmonary Bypass, Lung Injury.
What interventions are being tested in trial NCT04296071?
The interventions under investigation include: Research study (OTHER).
Who is sponsoring clinical trial NCT04296071?
This trial is sponsored by Sophia Koutsogiannaki, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04296071 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary Bypass
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
-
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
ACTIVE NOT RECRUITING · Phase 3
-
SPY Imaging System: Its Role in Pediatric Cardiac Surgery
COMPLETED
-
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
COMPLETED · NA
-
Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.